These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 29614525

  • 1. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G.
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [Abstract] [Full Text] [Related]

  • 2. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G, Sabbagh E, Hugon-Rodin J.
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [Abstract] [Full Text] [Related]

  • 3. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.
    Lancet; 1995 Dec 16; 346(8990):1593-6. PubMed ID: 7500751
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J, Gompel A, Plu-Bureau G.
    Eur J Endocrinol; 2014 Dec 16; 171(6):R221-30. PubMed ID: 25012200
    [Abstract] [Full Text] [Related]

  • 5. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N, Smith KP.
    Ann Pharmacother; 2010 May 16; 44(5):898-903. PubMed ID: 20371756
    [Abstract] [Full Text] [Related]

  • 6. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
    van Vlijmen EF, Wiewel-Verschueren S, Monster TB, Meijer K.
    J Thromb Haemost; 2016 Jul 16; 14(7):1393-403. PubMed ID: 27121914
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
    Bitzer J.
    J Fam Plann Reprod Health Care; 2013 Oct 16; 39(4):304-5. PubMed ID: 24062506
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J, Amy JJ, Beerthuizen R, Birkhäuser M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C.
    J Fam Plann Reprod Health Care; 2013 Jul 16; 39(3):156-9. PubMed ID: 23585363
    [No Abstract] [Full Text] [Related]

  • 12. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J, Amy JJ, Beerthuizen R, Birkhäuser M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C.
    Eur J Contracept Reprod Health Care; 2013 Jun 16; 18(3):143-7. PubMed ID: 23578274
    [No Abstract] [Full Text] [Related]

  • 13. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.
    Thromb Haemost; 1997 Dec 16; 78(6):1480-3. PubMed ID: 9423798
    [Abstract] [Full Text] [Related]

  • 14. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.
    Bergendal A, Persson I, Odeberg J, Sundström A, Holmström M, Schulman S, Björgell O, Kieler H.
    Obstet Gynecol; 2014 Sep 16; 124(3):600-609. PubMed ID: 25162263
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. First venous thromboembolism and hormonal contraceptives in young French women.
    Hugon-Rodin J, Horellou MH, Conard J, Flaujac C, Gompel A, Plu-Bureau G, and for the COntraception, REcurrent Venous Event (COREVE) investigators.
    Medicine (Baltimore); 2017 Aug 16; 96(34):e7734. PubMed ID: 28834877
    [Abstract] [Full Text] [Related]

  • 19. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F, Ramírez I, Pérez-Campos E, Latorre K, Lete I.
    Eur J Contracept Reprod Health Care; 2012 Feb 16; 17(1):7-29. PubMed ID: 22239262
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.